[1]
Caldarella, C. et al. 2014. The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to tyrosine-kinase inhibitors in patients with metastatic primary renal cell carcinoma. Radiology and Oncology. 48, 3 (Aug. 2014).